Success Stories: A Scientist-I from India Secures NIW Approval Just 6 Days After Case Submission, A Special Thanks to Premium Processing Upgrade
Client’s Testimonial:
“Thank you so much! It was really a great experience working with you. I really appreciate your time and efforts and preparing my application.”
On March 7th, 2024, we received another EB-2 NIW (National Interest Waiver) approval for a Scientist-I in the Field of Neurology (Approval Notice).
General Field: Neurology
Position at the Time of Case Filing: Scientist-I
Country of Origin: India
State of Residence at the Time of Filing: Alabama
Approval Notice Date: March 7th, 2024
Processing Time: 6 days (Premium Processing Requested)
Case Summary:
Our NIW (National Interest Waiver) client from India in the field of neurology, proposed to continue his research on employing mouse model systems, high-resolution imaging techniques, and other molecular and cell biology-informed techniques to discover the mechanisms and molecular pathology of Parkinson's disease, identify effective therapeutic targets, and improve patients' quality of life. We deduced that his research has great substantial merit and national importance among other applications as his research impacts global health and economics.
In addition, we noted that the 9 peer-reviewed journal articles (2 of them first-authored) resulting from his study have been published in at least 4 highly deemed peer-reviewed journals. Similarly, his peers have been influenced by his study as his research has been cited a total of 104 times, indicating that our client has had a major influence on other scholars’ understanding of these topics of how others in the field have directly benefited from his research.
In a similar vein, we noted that he achieved a Ph.D. in biochemistry and held the role of Scientist-I at a reputable university. Respected colleagues have also emphasized the significance of our client’s expertise and background in detailed endorsement letters. Moreover, his research has been financially supported by the National Institutes of Health (NIH), The Michael J. Fox Foundation, and Parkinson’s Foundation. In essence, this funding support for his studies serves as proof that his work harmonizes with the objectives of these funding organizations by providing valuable insights into the molecular mechanisms driving Parkinson's disease progression.
With compelling arguments, we showcased the significance of his research in advancing therapeutic interventions for Parkinson's disease, aiming to alleviate the economic burden associated with the condition. Through effective communication, North America Immigration Law Group successfully persuaded USCIS that our client's work has not only contributed to the field but has also offered fresh perspectives on the complex molecular pathways linked to Parkinson's disease progression and potential treatment options.
Consequently, the I-140 approval was granted for him to pursue his studies in the United States after opting for the expedited premium processing service, with the NIW case being approved within a mere 6 days. We extend our best wishes for his future pursuits and express our gratitude for entrusting us with his NIW case.